40K+ babies are born in the US annually from the use of donor gametes; ∼¼ are eggs (DE). Notably, in 2017, ∼¼ of the women > 40y that succeeded using ART did so with DE. DE is thus, common practice today as more women delay childbirth in lieu of professional/personal pursuits, causing them to “age-out” of traditional ART. DE has evolved from synching a recipient’s (REC) endometrium to a donor’s fresh retrieval (FRESH-O) + multi-embryo FRESH-ET to; (non-synchronized) frozen-embryo transfers (FROZ-ET) &/or the use of commercially-bought, frozen DE (COM-O) ± the use of PGT-A; all meant to optimize DE outcomes. We sought to examine trends over time re: psychology, cost, choice, genetics and ease. Retrospective analysis. From 1/2014-12/2019, we completed 462 DE transfers in 241 REC using a total of 163 donors (avg: 2-emb ET/REC). We analyzed donor characteristics & cycle repeats, &, over time, FRESH-O vs. COM-O, SOLE (1 REC) vs. SHARED (2 REC), FRESH-ET vs. FROZ-ET, PGT-A or not, single (SET) vs. double (DET) ET. Primary outcome was ongoing (> 8 wks) pregnancy + live birth rate (OP/LB). Stats: Chi Square was used. Of donors, 98 (60%) were FRESH-O; 65 (40%) were COM-O. 29 (30%) FRESH-O donated greater than once (REPEAT) with embryos transferred to a total of 108 REC. On average, REPEATs had 3 retrievals (range 2-6), went to 4 REC (range 2-9) & their donations resulted in 7 ETs (range 2-23) creating 84 OP/LB; 3 per donor (range 1-9). A total of 74 “genetic half-siblings” were born to 76 REC from 23 donors. Assessing oocyte & ET type, FRESH-ETs using FRESH-O compared to COM-O yielded a higher OP/LB rate (51% vs. 27% p=.0007). In FRESH-O, OP/LB rates were similar in FRESH-ET & FROZ-ET (50% vs 41%, p=.08). For all DE cycles, PGT-A use increased over time (2014-16: 0.2%, 2018-19: 13%) with no OP/LB improvement (p=.9). 2-ETs led to a higher OP/LB compared to SET (50% vs. 37%, p=.007) but had a 15% twin rate. The program trended from 2-ET to SET over 6y (2014-2019), decreasing from 42% to 19% (p<.05); SET continues to dominate. As years progressed, we trended toward SOLE over SHARED and less COM-O due to SOLE’s superior OP/LB per ET. Of note, 60/75 (80%) SOLE (17 eggs/REC) & 28/30 (93%) SHARED (10 eggs/REC) donors made at least 1 OP/LB. ART continues to evolve. As OP/LB successes have become universally acceptable, primary treatment emphasis has expanded from best-pregnancy-rate-only to include healthy baby (and mother) & meeting patient concerns: cost, timing, ease, non-family genetic siblings. Trends in practice require continuous reevaluation. Moving away from 2-ET in favor of SET is mandatory. PGT-A’s role in DE appears unnecessary except for carrier-state issues. The combo of SOLE, FRESH-O + readied REC continues to provide the best absolute OP/LB but COM-O and FROZ-ET add choice and convenience. Sharing donors, whether through FRESH-O or COM-O decreases cost & the # of supernumerary embryos but also increases the number of REC per donor, and therefore genetically-related offspring in the background of consumer testing unraveling anonymity. Donors and intended parents require full & appropriate counseling.